Human melanoma cells inhibit the earliest differentiation steps of human Langerhans cell precursors but failed to affect the functional maturation of epidermal Langerhans cells

Tumour-derived factors suppress differentiation and function of in vitro generated DC. Here, we investigate the effect of two melanoma clones differing in their invasive and metastatic properties on the generation and/or functional maturation of human epidermal LC. LC were generated from CD34+ cord blood progenitors under GM-CSF/TNF-α/TGF-β1. CD34+ cells were co-cultured with or without melanoma cells using Transwell dishes. After 11 days of co-culture, CD34+-derived cells display a non-adherent undifferentiated morphology, a high level of monocytic CD14 marker, a down-regulated expression of LC markers (CD1a, E-cadherin) and DC markers (CD40, CD80, CD54, CD58, CD83, CD86, HLA-DR, HLA-class I). These cells were less potent than control LC in inducing allogeneic T cell proliferation. The generation of the CD14+ population was correlated with a decrease in the CD1a+ population, without any statistical differences between the two clones. Melanoma cells diverted the differentiation of CD34+ cells towards a dominant CD14+ population only if the progenitors were in an early growth phase. IL-10, TGF-β1 and VEGF were not responsible for these effects, as assessed by using blocking antibodies. By contrast, co-culture of fresh epidermal LC with melanoma cells did not affect their phenotype and function. Our data demonstrate that melanoma cells inhibit the earliest steps of LC differentiation, but failed to affect the functional maturation of epidermal LC. This suggests that melanoma cells participate in their own escape from immunosurveillance by preventing LC generation in the local cutaneous microenvironment. © 2001 Cancer Research Campaign http://www.bjcancer.com

[1]  S. Imamura,et al.  CD 34 + Hematopoietic Progenitors from Human Cord Blood Differentiate Along Two Independent Dendritic Cell Pathways in Response to GM-CSF + TNFoL , 2003 .

[2]  G. Shurin,et al.  Human Small Cell Lung Carcinoma and Carcinoid Tumor Regulate Dendritic Cell Maturation and Function , 2001, Modern Pathology.

[3]  M. Lotze,et al.  Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function. , 2001, Cancer research.

[4]  A. Cochran,et al.  Penetration of human metastatic melanoma cells through an authentic dermal-epidermal junction is associated with dissolution of native collagen types IV and VII , 2000, Melanoma research.

[5]  D. Schmitt,et al.  Transforming growth factor‐β1 and ultraviolet A1 radiation increase production of vascular endothelial growth factor but not endothelin‐1 in human dermal fibroblasts , 2000 .

[6]  M. Lotze,et al.  Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins , 2000, British Journal of Cancer.

[7]  C. Caux,et al.  Respective involvement of TGF‐β and IL‐4 in the development of Langerhans cells and non‐Langerhans dendritic cells from CD34+ progenitors , 1999, Journal of leukocyte biology.

[8]  E. Kriehuber,et al.  CD34+ cell-derived CD14+ precursor cells develop into Langerhans cells in a TGF-beta 1-dependent manner. , 1999, Journal of immunology.

[9]  Simon C Watkins,et al.  Tumor's other immune targets: dendritic cells , 1999, Journal of leukocyte biology.

[10]  J. Blay,et al.  Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. , 1998, Blood.

[11]  D. Carbone,et al.  Defective function of Langerhans cells in tumor-bearing animals is the result of defective maturation from hemopoietic progenitors. , 1998, Journal of immunology.

[12]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[13]  A. Enk,et al.  Induction of tolerance by IL-10-treated dendritic cells. , 1997, Journal of immunology.

[14]  A. Enk,et al.  Dendritic cells as mediators of tumor‐induced tolerance in metastatic melanoma , 1997, International journal of cancer.

[15]  D. Hart,et al.  Dendritic cells: unique leukocyte populations which control the primary immune response. , 1997, Blood.

[16]  O. Majdic,et al.  TGF-beta 1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis. , 1997, Journal of immunology.

[17]  D. Carbone,et al.  Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells , 1996, Nature Medicine.

[18]  O. Majdic,et al.  TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. , 1996, Journal of immunology.

[19]  J. Banchereau,et al.  CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha , 1996, The Journal of experimental medicine.

[20]  D. Strunk,et al.  Generation of human dendritic cells/Langerhans cells from circulating CD34+ hematopoietic progenitor cells. , 1996, Blood.

[21]  J. Banchereau,et al.  Functional expression of CD40 antigen on human epidermal Langerhans cells. , 1995, Journal of immunology.

[22]  K. Dutt,et al.  Vasculotropin/Vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultued in vitro , 1995, Journal of cellular physiology.

[23]  O. Berthier‐Vergnes,et al.  Deficiency of ganglioside biosynthesis in metastatic human melanoma cells: relevance of CMP‐NeuAc: LacCer α2‐3 sialyltransferase (GM3 synthase) , 1995, FEBS letters.

[24]  J. Banchereau,et al.  Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. , 1994, International Immunology.

[25]  J. Banchereau,et al.  Interleukin‐10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells , 1994, European journal of immunology.

[26]  O. Berthier‐Vergnes,et al.  Expression of PNA‐binding sites on specific glycoproteins by human melanoma cells is associated with a high metastatic potential , 1994, Journal of cellular biochemistry.

[27]  A. Cochran,et al.  Expression of peanut agglutinin-binding glycoconjugates in primary melanomas with high risk of metastases , 1993, The Lancet.

[28]  A. Cochran,et al.  Variations in the distribution, frequency, and phenotype of Langerhans cells during the evolution of malignant melanoma of the skin. , 1993, The Journal of investigative dermatology.

[29]  J. Banchereau,et al.  GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells , 1992, Nature.

[30]  J. Tikerpae,et al.  Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. , 1992, Journal of immunology.

[31]  A. Cochran,et al.  Quantitative alterations in cutaneous Langerhans cells during the evolution of malignant melanoma of the skin. , 1988, The Journal of investigative dermatology.